Your browser doesn't support javascript.
loading
EGFR -mutant non-small cell lung cancer patients harboring CDK4 amplification show favorable response to afatinib: Two case reports.
Zhan, Shuting; Cheng, Bo; Liu, Xiwen; Li, Jianfu; Bai, Ge; Cai, Qi; Wang, Huiting; Xiang, Yang; Li, Chunyan; He, Jianxing; Liang, Wenhua.
Afiliação
  • Zhan S; Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University & Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong 510120, China.
  • Cheng B; Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University & Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong 510120, China.
  • Liu X; Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University & Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong 510120, China.
  • Li J; Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University & Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong 510120, China.
  • Bai G; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Health & The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China.
  • Cai Q; Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University & Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong 510120, China.
  • Wang H; Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University & Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong 510120, China.
  • Xiang Y; Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University & Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong 510120, China.
  • Li C; Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University & Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong 510120, China.
  • He J; Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University & Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong 510120, China.
  • Liang W; Southern Medical University, Guangzhou, Guangdong 510120, China.
Chin Med J (Engl) ; 137(12): 1465-1467, 2024 Jun 20.
Article em En | MEDLINE | ID: mdl-38775179
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Carcinoma Pulmonar de Células não Pequenas / Quinase 4 Dependente de Ciclina / Receptores ErbB / Afatinib / Neoplasias Pulmonares Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Carcinoma Pulmonar de Células não Pequenas / Quinase 4 Dependente de Ciclina / Receptores ErbB / Afatinib / Neoplasias Pulmonares Idioma: En Ano de publicação: 2024 Tipo de documento: Article